|
|
||||||||
1Department of Biomedicine and Surgery, Division of Cell Biology; and 2Diabetes Research Centre, Faculty of Health Sciences, Linköping University, Linköping, Sweden
Submitted 18 November 2005 ; accepted in final form 20 June 2006
Insulin and insulin-like growth factor I (IGF-I) are known to affect cardiovascular disease. We have investigated ligand binding and the dose-response relationship for insulin and IGF-I on vascular smooth muscle cells (VSMCs) at the receptor level. VSMCs from rat thoracic aorta were serum starved, stimulated with IGF-I or insulin, lysed, immunoprecipitated, and analyzed by Western blot. D-[U-14C]Glucose accumulation and [6-3H]thymidine incorporation into DNA were also measured. Specific binding of both insulin and IGF-I was demonstrated, being higher for IGF-I. Both IGF-I receptor (IGF-IR) and insulin receptor (IR)
-subunits were detected and coprecipitated after immunoprecipitation (IP) against either of the two. No coprecipitation was found after reduction of disulphide bonds with dithiotreitol before IP. After stimulation with 1010109 M IGF-I, IP of the IGF-IR, or IR
-subunit and immunoblot with anti-phosphotyrosine antibody, we found two distinct bands indicating phosphorylation of both the IGF-IR and the IR
-subunit. Stimulation with 1010109 M insulin and IP against the IGF-IR did not show phosphorylation of either
-subunit, whereas after IP of the IR we found phosphorylation of the IR
-subunit. [14C]Glucose accumulation and [3H]thymidine incorporation were elevated in cells stimulated with IGF-I at 1010107 M, reaching maximum by 109 M. Insulin stimulation showed measurable effects only at supraphysiological concentrations, 108107 M. In conclusion, coprecipitation of both the IGF-IR and the IR
-subunit indicates the presence of hybrid insulin/IGF-I receptors in VSMC. At a physiological concentration, insulin activates the IR but does not affect either glucose metabolism or DNA synthesis, whereas IGF-I both activates the receptor and elicits biological effect.
insulin-like growth factor I; ligand binding; receptor phosphorylation; immunopreciptation; dexoyribonucleic acid synthesis; glucose metabolism
This article has been cited by other articles:
![]() |
N. Engberding, A. San Martin, A. Martin-Garrido, M. Koga, L. Pounkova, E. Lyons, B. Lassegue, and K. K. Griendling Insulin-Like Growth Factor-1 Receptor Expression Masks the Antiinflammatory and Glucose Uptake Capacity of Insulin in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 408 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xue and K. B Michels Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schaafsma, K. D. McNeill, G. L. Stelmack, R. Gosens, H. A. Baarsma, B. G. J. Dekkers, E. Frohwerk, J.-M. Penninks, P. Sharma, K. M. Ens, et al. Insulin increases the expression of contractile phenotypic markers in airway smooth muscle Am J Physiol Cell Physiol, July 1, 2007; 293(1): C429 - C439. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |